dexmedetomidine has been researched along with Alloxan Diabetes in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (85.71) | 24.3611 |
| 2020's | 3 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Huan, Y; Tailaiti, T; Wang, J; Wu, J; Yang, L; Zou, T | 1 |
| Ciftel, S; Mercantepe, F; Mercantepe, T; Rakici, SY; Tumkaya, L | 1 |
| Ji, Z; Liang, G; Wang, L; Wang, S | 1 |
| Bo, Z; Fang, Z; Kang, L; Yayi, H; Zhongyuan, X | 1 |
| Li, J; Li, K; Li, L; Zhao, Y; Zhou, N | 1 |
| Chang, JH; Jin, MM; Liu, JT | 1 |
| Arslan, M; Aydın, ME; Bayraktar, AC; Erbatur, ME; Kavutçu, M; Sezen, ŞC | 1 |
| Lin, B; Lu, Y; Zhong, J | 1 |
| Bo, Z; Hong, C; Huaxin, W; Shaoqing, L; Yayi, H; Yeda, X; Zhongyuan, X | 1 |
| Cheng, XY; Gao, Q; Gu, XY; Hu, J; Li, XH; Li, ZH; Meng, Y; Wang, Y | 1 |
| Choi, YS; Jun, JH; Kim, SH; Oh, JE; Oh, YJ; Shin, EJ | 1 |
| Chen, H; Deng, L; Wang, G; Wei, N; Zhang, Z | 1 |
| Choi, YS; Hwang, HJ; Jun, JH; Oh, JE; Oh, YJ; Shin, EJ | 1 |
| Cheng, X; Gao, Q; Hu, J; Li, X; Li, Z; Wang, Y; Ye, H | 1 |
| Geng, J; Guo, XY; Li, M; Li, ZQ; Ma, D; Masters, J; Sun, YB; Wang, DX; Wang, SL; Yu, ZY | 1 |
| Brummett, CM; Lirk, P | 1 |
| Cao, D; Cao, J; Chen, L; Cong, H; Wang, M; Xiang, H; Yang, Y; Ying, T | 1 |
| Alkan, M; Arslan, M; Comu, FM; Kip, G; Kiraz, HA; Ozer, A; Sivgin, V | 1 |
| Alkan, M; Arslan, M; Bilge, M; Çelik, A; Erdem, Ö; Kavutçu, M; Kip, G; Kiraz, HA; Özer, A; Şıvgın, V | 1 |
| Li, W; Wang, H; Wang, Q; Xing, X; Zeng, X | 1 |
| Arslan, M; Comu, FM; Isik, B; Kesimci, E; Ozturk, L | 1 |
21 other study(ies) available for dexmedetomidine and Alloxan Diabetes
| Article | Year |
|---|---|
Dexmedetomidine Leads to the Mitigation of Myocardial Ischemia/Reperfusion-Induced Acute Lung Injury in Diabetic Rats Via Modulation of Hypoxia-Inducible Factor-1α.
Topics: Acute Lung Injury; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lung; Male; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Signal Transduction | 2022 |
Radioprotective effects of α2-adrenergic receptor agonist dexmedetomidine on X-ray irradiation-induced pancreatic islet cell damage.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Insulin-Secreting Cells; Islets of Langerhans; Rats; X-Rays | 2023 |
[Dexmedetomidine hydrochloride up-regulates expression of hypoxia inducible factor-1α to alleviate renal ischemiareperfusion injury in diabetic rats].
Topics: Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Kidney; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2019 |
Dexmedetomidine attenuates P2X4 and NLRP3 expression in the spine of rats with diabetic neuropathic pain.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Blotting, Western; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Disease Models, Animal; Interleukin-1beta; Male; Microscopy, Electron, Transmission; Neural Conduction; NLR Family, Pyrin Domain-Containing 3 Protein; Pain Threshold; Random Allocation; Rats, Sprague-Dawley; Receptors, Purinergic P2X4; Reproducibility of Results; Signal Transduction; Spine; Streptozocin; Sural Nerve; Time Factors | 2019 |
Dexmedetomidine Attenuates Myocardial Ischemia-Reperfusion Injury in Diabetes Mellitus by Inhibiting Endoplasmic Reticulum Stress.
Topics: Animals; Apoptosis; Cell Line; Creatine Kinase, MB Form; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endoplasmic Reticulum Stress; Fibrosis; Heat-Shock Proteins; Male; Membrane Glycoproteins; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Protein Disulfide-Isomerases; Rats, Sprague-Dawley; Signal Transduction; Transcription Factor CHOP; Troponin T | 2019 |
Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
Topics: Animals; Apoptosis; Cardiotonic Agents; Dexmedetomidine; Diabetes Mellitus, Experimental; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Streptozocin | 2020 |
Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats.
Topics: Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Kidney; Laparotomy; Lipid Peroxidation; Lower Extremity; Male; Oxidative Stress; Rats; Rats, Wistar; Reperfusion Injury; Streptozocin | 2017 |
The Therapeutic Effect of Dexmedetomidine on Rat Diabetic Neuropathy Pain and the Mechanism.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Glutamic Acid; Hyperalgesia; Inflammation; Interleukin-1beta; Male; Microglia; Pain Threshold; Rats, Sprague-Dawley; Spinal Cord; Tumor Necrosis Factor-alpha; Yohimbine | 2017 |
Dexmedetomidine protects against renal ischemia and reperfusion injury by inhibiting the P38-MAPK/TXNIP signaling activation in streptozotocin induced diabetic rats.
Topics: Animals; Carrier Proteins; Dexmedetomidine; Diabetes Mellitus, Experimental; Kidney; Male; p38 Mitogen-Activated Protein Kinases; Protective Agents; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Streptozocin | 2017 |
[Effect of dexmedetomidine postconditioning on myocardial ischemia-reperfusion injury and inflammatory response in diabetic rats].
Topics: Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Inflammation; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Sprague-Dawley | 2017 |
Renoprotective effects of dexmedetomidine against ischemia-reperfusion injury in streptozotocin-induced diabetic rats.
Topics: Animals; Apoptosis; Cytoprotection; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hemodynamics; Kidney; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Streptozocin | 2018 |
The cardioprotective effect of dexmedetomidine on regional ischemia/reperfusion injury in type 2 diabetic rat hearts.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Arrhythmias, Cardiac; Cytoprotection; Dexmedetomidine; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Heart Rate; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phosphorylation; Rats, Sprague-Dawley; Troponin T | 2019 |
Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus.
Topics: Animals; Autophagy; Cardiotonic Agents; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Heart; Heart Ventricles; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Streptozocin; Ventricular Function, Left | 2019 |
Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
Topics: Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Heart; Ischemic Postconditioning; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Phosphatidylinositol 3-Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction | 2018 |
Dexmedetomidine enhances ropivacaine-induced sciatic nerve injury in diabetic rats.
Topics: Adjuvants, Anesthesia; Anesthetics, Local; Animals; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Drug Synergism; Inflammation Mediators; Male; Nerve Block; Neural Conduction; Peripheral Nerve Injuries; Rats, Sprague-Dawley; Ropivacaine; Sciatic Nerve | 2019 |
Regional anaesthesia, diabetic neuropathy, and dexmedetomidine: a neurotoxic combination?
Topics: Anesthesia, Conduction; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Rats; Ropivacaine; Sciatic Nerve | 2019 |
Protective effect of dexmedetomidine against diabetic hyperglycemia-exacerbated cerebral ischemia/reperfusion injury: An in vivo and in vitro study.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Apoptosis; Dexmedetomidine; Diabetes Mellitus, Experimental; Disease Models, Animal; Hyperglycemia; In Vitro Techniques; Infarction, Middle Cerebral Artery; Inflammation; Male; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Reactive Oxygen Species; Reperfusion Injury; Signal Transduction | 2019 |
Effect of dexmedetomidine on erythrocyte deformability during ischaemia-reperfusion injury of heart in diabetic rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Disease Models, Animal; Erythrocyte Deformability; Male; Myocardial Reperfusion Injury; Rats, Wistar | 2014 |
Dexmedetomidine protects from post-myocardial ischaemia reperfusion lung damage in diabetic rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Glutathione Transferase; Lung; Lung Injury; Male; Malondialdehyde; Myocardial Ischemia; Myocardial Reperfusion Injury; Random Allocation; Rats; Rats, Wistar | 2015 |
Dexmedetomidine Protects against Transient Global Cerebral Ischemia/Reperfusion Induced Oxidative Stress and Inflammation in Diabetic Rats.
Topics: Animals; Brain Ischemia; Cytokines; Dexmedetomidine; Diabetes Mellitus, Experimental; Hemodynamics; Inflammation; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2016 |
Effect of dexmedetomidine on erythrocyte deformability during ischemia-reperfusion injury of liver in diabetic rats.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Dexmedetomidine; Diabetes Mellitus, Experimental; Erythrocyte Deformability; Hypnotics and Sedatives; Liver; Male; Rats; Rats, Wistar; Reperfusion Injury | 2012 |